References
- WHO: Cancer pain relief. With a guide to opioid availability. Geneva 1996
- Caplan RA, Southam M. Transdermal drug delivery and its application to pain control. Adv Pain Res Ther 1990;14:233–40
- Grond S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmaco kinet 2000;38:59–89
- Payne R. Experience with transdermal fentanyl in advanced cancer pain. Eur J Pain 1990; 11: 98–101
- Zech D, Grond S, Lynch J. Subcutaneous and transdermal administration of opioids in cancer pain. Eur J Pain 1993;14:69–78
- Picard PR, Tramer MR, McQuay HJ, Moore RA. Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 1997;72:309–18
- Finco G, Polati E, Bartoloni A, Milan B, Zanoni L, Valle L. Intravenous patient-controlled analgesia (PCA) in the treatment of postoperative pain: rationale and clinical application. Chir Ital 1995;74:20–5
- Heel RC, Brodgen RN, Speight TM, Avery GS. Burprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs 1979;17:81–119
- Budd K. High dose buprenorphine for postoperative analgesia. Anaesthesia 1981;36:900–3
- Benedetti F, Vighetti S, Amanzio M, et al. Dose–response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain 1998;74:205–11
- Budd K. Buprenorphine and the transdermal system – the ideal match in pain management. Int J Clin Pract Suppl 2003;133:9–14
- Böhme K, Likar R. Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomized, double-blind, placebo-controlled study. The Pain Clinic 2003;15:193–202
- Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther 2003; 25: 150–168
- Sorge J, Sittl R. Transdermal buprenorphine in chronic pain: results from a phase III, randomized, double-blind, placebo-controlled multicenter study. Clin Ther 2004;26:1808–20
- Transtec. Summary of product characteristics. 2001
- Nossol S, Schwarzbold M, Stadler T. Treatment of pain with sustained-release tramadol 100, 150, 200 mg: results of a post-marketing surveillance study. Int J Clin Pract 1998;52;115–21
- Radbruch L, Sabatowski R, Petzke F, Brunsch-Radbruch A, Grond S, Lehmann KA. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliative Med 2001;15: 309–21
- Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. New Engl J Med 2000;342: 1878–86
- Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New Engl J Med 2000;342:1887–92
- Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? New Engl J Med 2000;342:1907–9
- Janssen-Cilag. SmPC Durogesic SMAT. Section 4.1. 2004